Funnelfeedr Logo

BridgeBio International GmbH

Sverige502099-9289Active

Developing transformative medicines for rare genetic conditions quickly.

Biotechnology/Pharmaceutical Companybridgebio.com

Oversikt

1–4
Ansatte
Ukjent
Omsetning
2025
Grunnlagt

Nøkkelbeslutningstakere

Andrea Ellis

Director

Neil Kumar, Ph.D.

Chief Executive Officer, Director

Frank McCormick, Ph.D.

Director, Chairman of Oncology

James C. Momtazee

Senior Advisor, Transactions; Director

+10 flere kontakter i Funnelfeedr

Beskrivelse

BridgeBio Pharma is a company dedicated to developing transformative medicines for patients suffering from rare genetic conditions. They aim to bridge the gap between scientific advancements and meaningful treatments for underserved populations. The organization operates using a unique, decentralize...

Tagger

B2BB2CPharmaceuticalsProfessional ServicesTechnologyWhite Collar

Nøkkelord

BiotechnologyClinical TrialsDrug DevelopmentGenetic DiseasesHub-and-Spoke ModelRare Diseases

Teknologier i bruk

Tailwind CSSMarketoBootstrapGoogle Tag ManagerOneTrustSanity

Bedriftsinformasjon

Bransje
Ukjent
Juridisk form
Utländsk juridisk person
MVA-nummer
SE502099928901

Beslutningstakere

14 kontakter i Funnelfeedr

Andrea Ellis

Director

Neil Kumar, Ph.D.

Chief Executive Officer, Director

Frank McCormick, Ph.D.

Director, Chairman of Oncology

James C. Momtazee

Senior Advisor, Transactions; Director

Ronald J. Daniels

Director

Fred Hassan

Director

Ali J. Satvat

Director

Charles Homcy, M.D.

Chairman of Pharmaceuticals, Lead Director

Douglas Dachille

Director

Hannah A. Valantine, M.D.

Director

Eric Aguiar, M.D.

Director

Andrew W. Lo, Ph.D.

Director

Jennifer E. Cook

Senior Advisor, Commercial; Director

Randy Scott, Ph.D.

Director

Lignende bedrifter

20 lignende bedrifter i Funnelfeedr

Utforsk mer

Spørsmål om BridgeBio International GmbH

Vil du se Funnelfeedr i aksjon?

Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.

Book en demo